Physician
Corridor Primary Care, PA
Corridor Primary Care, PA was paid $3.23M by Medicaid between Oct 2018 and Dec 2024, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoCORRIDOR PRIMARY CARE, PA
SAN MARCOS, TX 78666
SAN MARCOS, TX 78666
33aNPI1124050836assigned 07/06/2006
33bProvider typeInternal Medicine Physician
28Total paid$3.23M
24GClaims117,579
24DCodes billed41
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Texas
Rank by total paid#14 of 1,028
Median peer was paid$10K
This provider vs. median310×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 69 | $540.96 | |
| 2020 | 5,477 | $124K | |
| 2021 | 36,534 | $888K | |
| 2022 | 35,433 | $929K | |
| 2023 | 25,320 | $768K | |
| 2024incomplete | 14,746 | $520K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 18,864 | 17,518 | $967K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 17,940 | 16,876 | $657K |
| S8301 | Infection control supplies, not otherwise specified | 12% | 25,042 | 22,854 | $384K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.1% | 3,812 | 3,719 | $295K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.3% | 20,840 | 9,966 | $205K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.4% | 2,253 | 2,184 | $111K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 1,437 | 1,412 | $107K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 1,169 | 1,148 | $98K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.6% | 10,151 | 9,627 | $86K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.1% | 520 | 504 | $69K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.9% | 2,088 | 2,027 | $60K |
| 99429 | 1.7% | 1,763 | 1,714 | $56K |
29 more codes
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.4% | 327 | $44K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 376 | $34K |
| 90461 | <1% | 3,420 | $19K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 586 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 510 | $7K |
| 0071A | <1% | 148 | $6K | |
| 0072A | <1% | 62 | $2K | |
| 0082A | <1% | 52 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 78 | $1K |
| 87807 | <1% | 104 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 66 | $901.53 |
| 96160 | <1% | 320 | $671.47 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 27 | $669.58 |
| 0083A | <1% | 14 | $480.00 | |
| 0081A | <1% | 12 | $408.00 | |
| 83655 | <1% | 27 | $305.10 | |
| 90686 | <1% | 3,500 | $72.61 | |
| 81002 | <1% | 13 | $37.96 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 25 | $1.15 |
| 90619 | <1% | 29 | $0.12 | |
| 90671 | 0% | 160 | $0.00 | |
| 90670 | 0% | 773 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 398 | $0.00 |
| 90633 | 0% | 12 | $0.00 | |
| 90698 | 0% | 263 | $0.00 | |
| 90680 | 0% | 173 | $0.00 | |
| 90656 | 0% | 199 | $0.00 | |
| 90620 | 0% | 12 | $0.00 | |
| 90651 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOMSTOCK, MICHELLE (OFFICE MANAGER)